Goran Koraćević,Milovan Stojanović,Marija Zdravković et al.
Goran Koraćević et al.
Refractory arterial hypertension (HTN) is a newly described severe phenotype of anti-hypertensive therapy failure. It is defined as uncontrolled blood pressure on (near-)maximal treatment using ≥ 5 antihypertensive drugs, two of which are ...
Promising results amid persistent disparities in real-world adherence to multitarget stool DNA testing [0.03%]
前景光明但多靶点粪便DNA检测实际应用中仍存在差异
Eyad Gadour,Raffaella Rima,Antonio Facciorusso
Eyad Gadour
Real-world comparative safety and effectiveness of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation: a prospective cohort study [0.03%]
利伐沙班与华法林治疗非瓣膜性房颤的现实世界安全性及有效性比较：前瞻性队列研究
Nawal Alsubaie,Zafar Ali Shah,Muhammad Ilyas et al.
Nawal Alsubaie et al.
Background: Direct oral anticoagulants (DOACs) provide several advantages over warfarin for stroke prevention in atrial fibrillation, particularly among patients with unstable or difficult-to-control international normali...
Jenyfer María Fuentes-Mendoza,Marcio José Concepción-Zavaleta,Julian A García-Ramírez et al.
Jenyfer María Fuentes-Mendoza et al.
Prediabetic neuropathy refers to early dysfunction of peripheral and autonomic nerves and may be present in individuals with impaired glucose regulation before the diagnosis of type 2 diabetes. Epidemiological evidence suggests that a subst...
Clinical efficacy and cost per improved outcome of treatments for generalized myasthenia gravis: evidence from a network meta-analysis and cost-per-responder analysis [0.03%]
一项针对全身型重症肌无力治疗的临床疗效及改善结局的成本：来自网状Meta分析和每个反应者成本分析的证据
A Gordon Smith,Ali A Habib,Cynthia Z Qi et al.
A Gordon Smith et al.
Objective: To indirectly compare the efficacy and value of biologic therapies for acetylcholine receptor antibody-positive generalized myasthenia gravis (gMG) using a network meta-analysis (NMA) of pivotal trials and a co...
Correction [0.03%]
改正错误
Published Erratum
Current medical research and opinion. 2026 Jul 19:1. DOI:10.1080/03007995.2026.2706895 2026
A quarter-century of montelukast: clinical lessons for adult and pediatric asthma and allergic rhinitis care [0.03%]
蒙特鲁卡斯使用二十五年的临床经验：成人和儿童哮喘以及过敏性鼻炎治疗的启示
Jan S Redfern,Megan A Smith
Jan S Redfern
Montelukast entered routine respiratory practice in the late 1990s and remains widely used for asthma, allergic rhinitis (AR), and exercise-induced bronchoconstriction (EIBC). Its continued use has been driven largely by once-daily oral adm...
Shuaib Nasser,Luca Bottazzi,Andrea Lang et al.
Shuaib Nasser et al.
Background: Nasal adrenaline spray is a novel needle-free alternative for the emergency treatment of anaphylaxis. Evidence on its cost-effectiveness versus adrenaline auto-injectors (AAIs) is currently limited. This analy...
Cross-publisher agreement on the defining principles of plain language summaries of publications (PLSPs) [0.03%]
关于发布物简洁摘要(PLSP)定义原则的跨出版机构协议
Sophie Nobes,Kelly Soldavin,Rachel Jenkins et al.
Sophie Nobes et al.
Introduced in 2020, plain language summaries of publications (PLSPs) are standalone articles that aim to expand the reach of scientific findings to non-specialist audiences using plain language and meaningful visuals. Despite increased publ...
Initiating dextromethorphan-bupropion extended release in patients with major depressive disorder: Delphi panel expert consensus recommendations [0.03%]
DXM-布普品缓释制剂治疗抑郁症的专家共识推荐建议
Anita H Clayton,Gus Alva,Phillip Bowman et al.
Anita H Clayton et al.
Objective: To establish consensus recommendations for initiating dextromethorphan-bupropion extended release (45 mg/105 mg) (AUVELITY) for the treatment of major depressive disorder (MDD) in adults. ...